Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$34,976,838
-$6,049,551 QoQ
Shares Held
607,026
-10.3% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#207
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Mar 31, 2026CallValue
$121,300
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $1,882,423,234 across 16 Drug Manufacturers - General names. BMY ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,817,391 | $457,328,271 | |
| 2 | LLY |
ELI LILLY & Co
|
308,951 | $370,565,128 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,054,383 | $263,988,215 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,763,525 | $222,803,748 | |
| 5 | JNJ |
Johnson & Johnson
|
783,288 | $198,931,653 | |
| 6 | AMGN |
Amgen Inc
|
516,543 | $187,050,551 | |
| 7 | PFE |
Pfizer Inc
|
3,628,237 | $87,367,946 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
607,026 | $34,976,838 |
All Filings in BMY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,976,838 | 607,026 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $121,300 | 2,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $41,026,389 | 676,445 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $29,218,381 | 541,683 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,634,242 | 457,522 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $24,224,714 | 523,325 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $33,139,587 | 543,361 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $30,052,307 | 531,335 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,219,804 | 468,106 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $17,150,727 | 412,972 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $24,334,573 | 448,729 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $26,235,110 | 511,306 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $32,956,795 | 567,829 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $35,779,513 | 559,492 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $37,574,545 | 542,123 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $37,061,373 | 515,099 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $35,417,819 | 498,211 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $29,383,046 | 381,598 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $24,388,806 | 333,956 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $19,018,745 | 305,032 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $16,530,263 | 279,369 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $15,803,865 | 236,514 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,243,559 | 241,463 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $14,567,559 | 234,847 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $14,038,225 | 232,845 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $13,301,442 | 226,215 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $11,435,785 | 205,163 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||